A detailed history of Act Capital Management, LLC transactions in Medicenna Therapeutics Corp. stock. As of the latest transaction made, Act Capital Management, LLC holds 149,070 shares of MDNA stock, worth $46,211. This represents 0.17% of its overall portfolio holdings.

Number of Shares
149,070
Previous 149,070 -0.0%
Holding current value
$46,211
Previous $173,000 28.32%
% of portfolio
0.17%
Previous 0.24%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$0.79 - $1.32 $2,709 - $4,527
-3,430 Reduced 2.25%
149,070 $173,000
Q4 2021

Feb 03, 2022

SELL
$1.53 - $2.85 $302,175 - $562,875
-197,500 Reduced 56.43%
152,500 $249,000
Q2 2021

Aug 16, 2021

BUY
$2.97 - $4.28 $1.04 Million - $1.5 Million
350,000 New
350,000 $1.05 Million

Others Institutions Holding MDNA

About Medicenna Therapeutics Corp.


  • Ticker MDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,637,504
  • Market Cap $21.6M
  • Description
  • Medicenna Therapeutics Corp., an immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer and other diseases. Its lead product is MDNA55, an interleukin- 4 (IL-4) EC that has completed Phase IIb clinical trial for the treatment of recurrent glioblastoma, as well as...
More about MDNA
Track This Portfolio

Track Act Capital Management, LLC Portfolio

Follow Act Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Act Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Act Capital Management, LLC with notifications on news.